Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results‐Medicare datac

Author:

Haas Naomi B.1,Song Yan2,Willemann Rogerio Jaqueline3,Zhang Su2ORCID,Carley Christopher2,Zhu JingJing2,Bhattacharya Rituparna3,Signorovitch James2,Sundaram Murali3

Affiliation:

1. University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

2. Analysis Group, Inc. Boston Massachusetts USA

3. Merck & Co., Inc. Rahway New Jersey USA

Abstract

ObjectivesThis study aimed to assess whether disease‐free survival (DFS) may serve as a predictor for long‐term survival among patients with intermediate‐high risk or high risk renal cell carcinoma (RCC) post‐nephrectomy when overall survival (OS) is unavailable.MethodsThe Surveillance, Epidemiology and End Results‐Medicare database (2007–2016) was used to identify patients with non‐metastatic intermediate‐high risk and high risk RCC post‐nephrectomy. Landmark analysis and Kendall's τ were used to evaluate the correlation between DFS and OS. Multivariable regression models were used to quantify the incremental OS post‐nephrectomy associated with increased time to recurrence among patients with recurrence, adjusting for baseline covariates.ResultsA total of 643 patients were analyzed; mean age of 75 years; >95% of patients had intermediate‐high risk RCC at diagnosis; 269 patients had recurrence post‐nephrectomy. For patients with versus without recurrence at the landmark points of 1, 3, and 5 years post‐nephrectomy, the 5‐year OS were 37.0% versus 70.1%, 42.3% versus 72.8%, and 53.2% versus 78.6%, respectively. The Kendall's τ between DFS and OS post‐nephrectomy was 0.70 (95% CI: 0.65, 0.74; p < 0.001). After adjusting for baseline covariates, patients with one additional year of time to recurrence were associated with 0.73 years longer OS post‐nephrectomy (95% CI: 0.40, 1.05; p < 0.001).ConclusionThe significant positive association of DFS and OS among patients with intermediate‐high risk and high risk RCC post‐nephrectomy from this study supports the use of DFS as a potential predictor of OS for these patients when OS data are immature.

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Urology

Reference26 articles.

1. American Cancer Society.Survival rates for kidney cancer [Internet].2021. Available from:https://www.cancer.org/cancer/kidney‐cancer/detection‐diagnosis‐staging/survival‐rates.html. Accessed 6 May 2021.

2. Cancer statistics, 2020

3. Grading of renal cell carcinoma

4. Validation of risk factors for recurrence of renal cell carcinoma: results from a large single‐institution series;Mijn JC;PLoS One,2019

5. Renal Cell Carcinoma: Diagnosis and Treatment, 1994–2003

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3